Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

Citi downgraded Hims & Hers to Sell from Neutral with a $25 price target Stay Ahead of the Market:Discover outperforming stocks and invest ...

Shares of Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) have been given a consensus recommendation of “Hold” by the ...

The moves come as Wall Street is gearing up for December's nonfarm payrolls reading, which is scheduled to come out at 8:30 a ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...

Two startups team up to help brands target TV viewers based on what and where they buy. And TikTok remains in will-they-won’t ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $27.67 which represents a slight increase of $0.77 or 2.86% from the prior close of $26.9. The stock opened at $27.68 and ...

Cedar Grove Capital Management, an investment management company, released its fourth quarter 2024 investor letter. A copy of ...